Research

Follow-on intravenous iron formulations in haemodialysis patients

A study into the efficiency of follow-on intravenous (IV) iron formulations compared to originator formulations in haemodialysis patients has shown the follow-on products to be less efficient at maintaining the same haemoglobin levels [1].

Follow-on glatiramer acetate (M356) claimed as equivalent to Copaxone

A multi-dimensional evaluation of the equivalence of a follow-on glatiramer acetate (M356) and the brand-name originator version (Copaxone) has been reported to show equivalence of biological and physicochemical properties, with no significant differences in the structure and function of the two products [1].

Generics News Research General

more

Biosimilars News Research General

more